Companies: 10,795·Total market cap: $144.5T
Xylo Technologies Ltd.

Xylo Technologies Ltd.

MDGSNASDAQHealthcare
$2.36
+$0.22(+10.28%)
Market Cap$178860624
P/E Ratio—
52W High$7.17
52W Low$1.5396
Overview
Foreign Private Issuer · Files 20-F / 6-K

Xylo Technologies Ltd. (MDGS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001618500 · MDGS · NASDAQ · as of Jun 9, 2026

Filing snapshot

607
Total Filings
EFFECT
Latest Form
2025-08-25
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001618500 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-04-30
Fiscal Year End
Apr 30, 2025
Accession No.
0001213900-25-037618
Primary Document
ea0238675-20f_xylotech.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001618500 · Accession 0001213900-25-037618

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2025-08-22
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2025-08-25
View
15-12G15-12G
FORM 15-12G
2025-08-22
View
25-NSE25-NSE
25-NSE
2025-08-22
View
POS AMPOS AM
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3
2025-08-22
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-08-22
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-08-22
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-08-22
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-08-22
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
2025-08-22
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-08-22
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-08-12
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-08-11
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-08-08
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-06-25
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-06-23
View
Showing 1–15 of 603 filingsForm 4 / 144 hidden· 607 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001618500  |  Exchange: NASDAQ · Healthcare

Xylo Technologies Ltd. (NASDAQ: MDGS) has submitted 607 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001618500, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Xylo Technologies Ltd.'s most comprehensive regulatory disclosure. The most recent Xylo Technologies Ltd. 10-K was filed on 2025-04-30 for fiscal year ending 2025. Historical MDGS 10-K annual reports are available from 2014 through 2025.

Investors researching Xylo Technologies Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TNFA SEC Filings →NUVO SEC Filings →VRAY SEC Filings →MNK SEC Filings →APTO SEC Filings →GMDA SEC Filings →HILS SEC Filings →PEAR SEC Filings →
→ MDGS Financials→ MDGS Earnings→ MDGS Insider Trades

Frequently Asked Questions

MDGS SEC Filings · 8 questions

Xylo Technologies Ltd. (MDGS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 607 filings and access original documents at no cost. Xylo Technologies Ltd.'s CIK is 0001618500.

MDGS SEC filingsXylo Technologies Ltd. SEC documentsfind MDGS 10-K